The board of directors of China Health Group Limited announced that on 25 March 2018, the company, Shenzhen Beike Ronghui Life Technology Company Limited and Shenzhen Ronghui Renhe Investment Management Company Limited entered into a strategic cooperation agreement, pursuant to which the parties agreed to cooperate in the areas: develop research centre for life sciences; consider the application of life sciences technology in the hospitals managed by the Group; and explore capital raising opportunities to fund the development of life sciences business. Beiki Ronghui Life Technology is a joint venture between Shenzhen Beike Biotechnology Co., Ltd. and Ronghui Renhe Investment Management established for the provision of operational and management services for innovative medical and healthcare value chain, spanning from cell storage, biological big data and health management. Ronghui Renhe Investment Management is an investment management company focusing on promoting the combined use of life sciences and artificial intelligence to develop innovative medical and wellness value chain. Currently Ronghui Renhe Investment Management has invested in six medical and healthcare projects in Guizhou, the People's Republic of China. To the best of the Directors' knowledge, information and belief having made all reasonable enquiries, Beike Ronghui Life Technology and Ronghui Renhe Investment Management and their respective ultimate beneficial owners are third parties independent of the Company and its connected persons. The Group is principally engaged in the provision of hospital management services. The Directors believe the Agreement provides an opportunity for the Group to cooperate with other industry participants to enrich its business scope.